tiprankstipranks
Advertisement
Advertisement
Tenax Therapeutics highlights key Phase 3 LEVEL trial
PremiumCompany AnnouncementsTenax Therapeutics highlights key Phase 3 LEVEL trial
29d ago
Tenax and Orion Secure Long-Term Levosimendan Supply Deal
Premium
Company Announcements
Tenax and Orion Secure Long-Term Levosimendan Supply Deal
1M ago
Tenax Therapeutics Updates Executive and Employee Severance Protections
Premium
Company Announcements
Tenax Therapeutics Updates Executive and Employee Severance Protections
1M ago
Tenax Therapeutics: Buy Rating Reiterated with $27 Price Target Unchanged on Compelling Phase 3 Opportunity
PremiumRatingsTenax Therapeutics: Buy Rating Reiterated with $27 Price Target Unchanged on Compelling Phase 3 Opportunity
3M ago
Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)
Premium
The Fly
Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)
3M ago
Tenax Therapeutics appoints Timothy Healey as chief commercial officer
Premium
The Fly
Tenax Therapeutics appoints Timothy Healey as chief commercial officer
3M ago
Cantor starts Tenax at Overweight into Phase 3 readout
PremiumThe FlyCantor starts Tenax at Overweight into Phase 3 readout
5M ago
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Tenax Therapeutics initiated with an Overweight at Cantor Fitzgerald
5M ago
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target raised to $34 from $25 at Guggenheim
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100